Transforming older adult disability through virtual, peer-led community rehabilitation: led by MSK charities
通过虚拟、同伴主导的社区康复来改变老年人的残疾:由 MSK 斯隆慈善机构领导
基本信息
- 批准号:106337
- 负责人:
- 金额:$ 40.89万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Good Boost Wellbeing Limited (Good Boost) is a rapidly growing UK SME delivering cutting-edge medical technology. Combined with the collaboration, expertise and network access of the four largest musculoskeletal charities\* and Oxford Brookes University, Good Boost's unique AI-powered technology has the potential to save the NHS £16.4m by 2025\. Through the expansion of digital community rehabilitation solutions, the project stands to generate a Year-3 post-project ROI of 39X. \*(Versus Arthritis, National Rheumatoid Arthritis Society, Arthritis Action, National Axial Spondyloarthropathy Society.)**Unmet Need**Musculoskeletal disorders (MSKDs), such as arthritis and back pain represent over 22% of the ill-health burden in the UK, costing the economy and NHS £100bn+ per year. Disproportionately impacting older adults, low income and BAME citizens, they create deep health inequalities. MSKD prevalence is rising, waiting times increasing and significant challenges are ahead to address backlogs post-COVID. Solutions are needed to deliver MSK-rehabilitation that don't require additional NHS resources.Trusted by clinicians and patients, MSK charities are the foremost support service to deliver care closer to home, aligning with the NHS strategy. However, with 18.8m people living with an MSK condition, there are not enough clinical staff or volunteers to provide rehabilitation services for all.**Solution**Good Boost's innovative AI MSK-rehabilitation technology will enable charities to deliver virtual group rehab classes through staff and volunteers. Every user will benefit from an AI-personalised programme. To date, an MVP solution has been co-designed and co-produced with patient and charity focus groups. This funding will support industrial research of a real-world pilot to further develop, test and validate the clinical technology, enabling national roll-out in 2022, and meeting the urgent need.**Market Opportunity**While there are AI-rehab products on the market, none deliver virtual community-based solutions. Emotional and peer support is proven to significantly improve uptake and continued engagement. Furthermore, no products work collaboratively with MSK charities. With older adults requiring high trust levels to download and use health apps, MSK charity collaboration has the potential to significantly increase reach and impact.2.41bn people need rehabilitation globally (WHO) representing a large international commercial opportunity. The annual global and UK addressable/serviceable markets are £15.4b/£4.65b and £0.51b/£0.32b respectively. CAGR is 7.7%.**Objectives**This industrial research project aims to complete product testing, co-production and research to achieve regulatory approval for public rollout and commercialisation 3-6 months post-project, to create a publically-accessible product which will address clinical rehab needs for MSKDs, and reduce health inequality.
Good Boost Wellbeing Limited(Good Boost)是一家快速发展的英国中小企业,提供尖端的医疗技术。结合四大肌肉骨骼慈善机构和牛津布鲁克斯大学的合作,专业知识和网络接入,Good Boost独特的人工智能技术有可能在2025年之前为NHS节省1640万英镑。通过数字社区康复解决方案的扩展,该项目将产生39倍的项目后第3年投资回报率。\*(与关节炎,国家风湿性关节炎协会,关节炎行动,国家中轴脊柱关节病协会。)**未满足的需求 ** 肌肉骨骼疾病(MSKD),如关节炎和背痛,占英国健康不良负担的22%以上,每年给经济和NHS造成1000亿英镑以上的损失。不均衡影响老年人,低收入和BAME公民,他们造成了深刻的健康不平等。MSKD患病率正在上升,等待时间增加,在COVID后解决积压问题方面面临重大挑战。我们需要解决方案来提供不需要额外NHS资源的MSK康复。MSK慈善机构受到临床医生和患者的信任,是最重要的支持服务,可以提供离家更近的护理,与NHS战略保持一致。然而,有1880万人患有MSK疾病,没有足够的临床工作人员或志愿者为所有人提供康复服务。Good Boost的创新AI MSK康复技术将使慈善机构能够通过工作人员和志愿者提供虚拟团体康复课程。每个用户都将受益于AI个性化计划。迄今为止,MVP解决方案已与患者和慈善焦点小组共同设计和共同制作。这笔资金将支持对现实世界试点的工业研究,以进一步开发,测试和验证临床技术,使其能够在2022年在全国推广,并满足迫切需求。市场机会 ** 虽然市场上有人工智能康复产品,但没有一个提供基于虚拟社区的解决方案。情感和同伴支持被证明可以显著提高吸收和持续参与。此外,没有产品与MSK慈善机构合作。由于老年人下载和使用健康应用程序需要高信任级别,MSK慈善合作有可能显著增加覆盖面和影响力。全球有24.1亿人需要康复(世卫组织),这代表着一个巨大的国际商业机会。每年全球和英国的可寻址/可服务市场分别为154亿英镑/465亿英镑和51亿英镑/32亿英镑。CAGR为7.7%。**目标 ** 该工业研究项目旨在完成产品测试、联合生产和研究,以获得监管部门批准,在项目后3-6个月内公开推出和商业化,创造一种公众可获得的产品,以满足MSKD的临床康复需求,并减少健康不平等。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 40.89万 - 项目类别:
Studentship
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
- 批准号:
10644490 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners
分享加:患有 T1D 的老年人及其护理伙伴的持续血糖监测和数据共享
- 批准号:
10660793 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
The Social-Medical Network: Using a Network Approach to Explore the Integration of Informal and Formal Care Networks of Older Adults
社会医疗网络:利用网络方法探索老年人非正式和正式护理网络的整合
- 批准号:
10724756 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
通过减少甲状腺激素处方来优化老年人的护理
- 批准号:
10733478 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Determining the ototoxic potential of COVID-19 therapeutics using machine learning and in vivo approaches
使用机器学习和体内方法确定 COVID-19 疗法的耳毒性潜力
- 批准号:
10732745 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Age-related differences in neurobiological systems supporting emotion
支持情绪的神经生物系统与年龄相关的差异
- 批准号:
10606216 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults with Multiple Chronic Conditions: A Sequential, Multiple Assignment, Randomized Trial
优化对患有多种慢性病的老年人进行远程医疗的减肥干预:一项序贯、多项分配、随机试验
- 批准号:
10583917 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Formation of a functional tendon enthesis during development and healing
在发育和愈合过程中形成功能性肌腱附着点
- 批准号:
10587399 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别: